Pharma News, 2020

Some drugmakers in China restarted production this week after an extended break for the Chinese New Year, but as the COVID-19 outbreak drags on, governments are trying to get a handle on whether it wi...

Astellas and Seattle Genetics impressed Wall Street last fall when their combination of Padcev and Merck’s Keytruda fought off advanced bladder cancer in previously untreated patients.

NEW YORK – The maker of a weight loss drug pulled it from the market Thursday at the request of U.

Takeda has announced topline data from the Phase III VISIBLE 2 clinical trial, showing that a subcutaneous formulation of Entyvio (vedolizumab) hit its primary endpoint in treating Crohn's...

Verona Pharma has released Phase II trial results for ensifentrine as a maintenance treatment for chronic obstructive pulmonary disease (COPD).

Janssen has announced interim data from its Phase IIIb STARDUST study, demonstrating that at week 16, 79% of patients with moderately to severely active Crohn’s disease (CD) achieved cli...

India’s Wockhardt, which has had its financial fortunes dampened for several years by FDA-related manufacturing issues, has decided to improve its cash flow by selling a plant and portfolio of produ...

Artificial intelligence has been used for the first time to instantly and accurately measure blood flow, in a study led by UCL and Barts Health NHS Trust.

The sickle cell disease market and patient support around the disease are both in the nascent stages.

Acorda Therapeutics suffered a major blow in late 2018 when it lost four patents on multiple sclerosis med Ampyra.

MSD has revealed that its cancer blockbuster Keytruda (pembrolizumab) significantly prolonged progression-free survival (PFS) when added to chemo in a triple-negative breast cancer tri...

GENEVA (Reuters) - China is dragging its heels in accepting help on the ground from international health specialists, diplomats and experts said on Thursday, noting four days after a World Hea...